An increasing total number of baseline symptoms was associated with an increased likelihood of treatment discontinuation , with an OR of 1.89 ( 95 % CI , 1.20-2 .96 ; P = .006 ) for 3 to 5 symptoms versus 0 to 2 symptoms .